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Abstract
Background: Visual evoked potentials (VEPs) are electrical potentials generated by neurons in the central nervous
system in response to visual stimuli. A series of positive and negative wavelets in response to flash-stimuli (flash-
VEP; FVEP) or reversing, iso-luminant patterns (pattern-VEP; PVEP) are recorded. Pathological conditions affecting the
post-retinal pathways can alter overall waveform morphology, and also affect wavelet peak times and amplitudes.
FVEPs have recently been described in horses, but more data on the variability within and between subjects is
required, to adequately interpret results from clinical equine patients. Therefore, the purpose of this study was to
describe the variability, repeatability and test-retest reliability of equine FVEPs in normal, adult horses.
Results: Equine FVEPs were recorded from one randomly selected eye in 17 horses, from both eyes in eight of
these horses, and also at two separate recording sessions in six horses. N1, P2, N2 and P4 wavelets were present in
100% of the recordings in all horses, while P1, N2a, P3 and P5 were only present in some recordings. Coefficients of
variation (CVs) were low for P2, N2 and P4 peak times, but higher for all amplitudes. There were no statistically
significant differences comparing peak times and amplitudes between eyes or between sessions. Coefficients of
repeatability (CRs) are reported for P2, N2 and P4 peak times between eyes (P2; 5 ms, N2; 18 ms, P4; 18 ms) and also
between sessions (P2; 5 ms, N2; 16 ms, P4; 39 ms). Intraclass correlation coefficients (ICCs), as an estimate of test-
retest reliability, was assessed to be fair to excellent for most parameters.
Conclusions: This study provides important data on variability, repeatability and test-retest reliability of FVEPs in
normal, adult horses. We conclude that P2, N2 and P4 peak times should be included in the evaluation of equine
FVEPs. The large inherent variability of FVEP amplitudes is likely to make them less suitable and useful for
establishing a diagnosis on their own in most clinical patients, but they may occasionally provide support to a
clinical diagnosis.
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Background
Visual evoked potentials (VEPs) are electrical poten-
tials generated by neurons in the central nervous sys-
tem in response to visual stimuli. These potentials in
response to flash-stimuli (flash-VEP;FVEP) or revers-
ing, iso-luminant patterns (pattern-VEP;PVEP), are re-
corded by electrodes placed on the scalp over the
visual cortex. Several pathological conditions affecting
the post-retinal pathways can alter overall morphology
of the recorded waveform and also affect wavelet peak
times and amplitudes [1].
In human medicine, recording of VEPs has many clin-
ical indications including evaluation of patients with
optic neuropathies, lesions compressing post-retinal
pathways, Alzheimer’s disease, glaucoma and central vis-
ual impairment (CVI) of different etiologies [2–7]. It is
well known that the appearance of FVEPs is variable [1,
8, 9] and it has been shown that PVEPs have lower vari-
ability in peak times, amplitudes and waveform morph-
ology, both within and between subjects [1, 10–12].
Therefore, PVEPs are most often preferred in clinical
human medicine. However, recording of PVEPs require
cooperation by the patient (fixation and focus on the
pattern) and FVEPs are therefore usually still the test of
choice in infants, as well as in uncooperative, sedated
and comatose patients [1].
In animals that cannot describe subjective symptoms,
it is difficult to evaluate visual impairment. Vision is
often severely reduced before the clinician can make a
definitive diagnosis of disturbed vision. The FVEP has
been used as an adjunct and objective test in the clinical
work-up of animal patients [13–15]. Although FVEPs
have been described in normal horses (Fig. 1) [16, 17],
more data on the variability within and between subjects
and evaluation of test-retest reliability is required, to ad-
equately interpret results from clinical equine patients.
Therefore, the purpose of this study was to describe the
variability, repeatability and test-retest reliability of
FVEPs recorded from healthy horses.
Results
Intra- and inter-individual variability for the three repli-
cates for each parameter are reported in Table 1. N1, P2,
N2 and P4 peaks were present in 100% of recordings in
all horses, while the remaining peaks (P1, N2a, P3 and
P5) were only present in some recordings (Table 1). In
general, intra- and inter-individual coefficient of vari-
ation (CV) values were lower for peak times compared
to amplitudes (Table 1).
Only wavelets present in all recordings were evaluated
in the subsequent analyses. Table 2 show the descriptive
data for the averaged measurement for each of these pa-
rameters in all horses.
The FVEP waveform was similar between eyes (Fig. 2).
There were no statistically significant differences be-
tween measurements from right and left eyes (p > 0.33)
(Table 3). Coefficients of variation between right and left
eyes were low for peak times but higher for amplitudes
(Table 3). The computed CR between eyes for each par-
ameter are reported in Table 3.
FVEP waveforms were similar between recording ses-
sions. Individual waveforms from two different recording
sessions in three horses are displayed in Fig. 3. Bland-
Altman plots including 95% LOA for P2, N2, P4 peak
times and N1P2, P2N2, N2P4 amplitudes are shown in
Fig. 4. The plot illustrates the agreement in measure-
ment between session 1 and 2. There were no statisti-
cally significant differences between first and second
measurements for any of the parameters (Table 4). Coef-
ficient of variations were low for peak times, but higher
for amplitudes (Table 4). The computed CR and intra-
class correlation coefficients (ICCs) for each parameter
are reported in Table 4.
Fig. 1 The equine FVEP. A series of positive and negative wavelets can be observed in the equine FVEP
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Discussion
We have examined the variability, repeatability and test-
retest reliability of FVEPs in normal, adult horses to
evaluate if this method may be a suitable, additional
diagnostic tool to use in the clinical work-up of equine
patients with ophthalmological and/or neurological dis-
ease. Before a new method can be used in clinical prac-
tice, its strengths and weaknesses have to be assessed, in
order to correctly interpret results from clinical patients
and be able to make adequate clinical decisions.
The FVEP waveform recorded in all 17 horses in this
study consisted of a series of positive and negative wave-
lets (P1, N1, P2, N2a, P3, N2, P4 and P5), as previously
reported [16, 17]. However, some wavelets were only
present in a limited number of recordings in all horses.
This is similar to results from several human studies.
Gastaut & Regis [8] showed that only about 20% of re-
cordings included all wavelets in the human FVEP
(peaks I-VI according to their nomenclature), but wave-
lets IV (around 80ms) and V (around 130 ms) were
present in practically all recordings and in all subjects.
In the ISCEV standard for human FVEPs, the waveform
is defined as a series of positive and negative wavelets
(N1, P1, N2, P2, N3 and P3). Of these wavelets, N2
(around 90ms) and P2 (around 120 ms) are described as
the most robust components [1]. In our study on the
equine FVEP, wavelets N1, P2, N2 and P4 were present
in all recordings in all 17 horses. Both the intra- and
inter-individual coefficients of variation were low (5–
11%) for the peak times of P2, N2 and P4. Although
present in all recordings, the N1 peak time was shown
to be more variable (up to 17%), probably because this
low-amplitude wavelet is occasionally difficult to localize
and measure precisely. Our results support that the P2,
N2 and P4 peak times are most robust, and should be
included in the evaluation of equine clinical patients. Al-
though not present in all recordings, the N2a, P3 and P5
wavelets may still provide valuable clues regarding trans-
mission and processing of visual stimuli. Hence, they
may be useful for evaluation of certain conditions, or be
valuable for our understanding of processing of visual
input, but this warrants further studies.
Our results show that there is a substantial intra- and
inter-individual variability in amplitudes in the equine
FVEP. A substantial variability in amplitudes has also
been shown in studies on the human FVEP [8, 9]. In our
study, the coefficients of variation for the amplitudes
present in all recordings in all horses (N1P2, P2N2 and
N2P4), were up to 30% within horse and more than
twice that (up to 64%) between horses. Hence, the vari-
ation for these amplitude parameters was considerably
higher than that for peak times. Based on the results of
our study, a wide range of amplitudes must be consid-
ered normal in the FVEP recorded from sedated horses.
Therefore, the mere presence of a wavelet and its peak
Table 1 Evaluation of three FVEP triplicates from one randomly selected eye in 17 horses
Parameter No / 51 recordings % of recordings Mean SDintra-individual SDinter-individual CVintra-individual CVinter-individual
P1 (ms) 20 39% 15 3.4 2.3 23% 15%
N1 (ms) 51 100% 25 4.1 4.2 16% 17%
P2 (ms) 51 100% 54 3.3 3.6 6% 7%
N2a (ms) 29 57% 99 7.9 13.5 8% 14%
P3 (ms) 29 57% 115 11.2 7.2 10% 6%
N2 (ms) 51 100% 136 9.8 7.0 7% 5%
P4 (ms) 51 100% 213 14.9 23.8 7% 11%
P5 (ms) 14 27% 345 12.0 23.6 3% 7%
N1P2 (μV) 51 100% 4.1 0.8 2.6 19% 64%
P2N2 (μV) 51 100% 7.1 1.6 3.2 22% 45%
N2aP3 (μV) 29 57% 1.6 0.9 0.8 57% 49%
N2P4 (μV) 51 100% 7.7 2.3 2.8 30% 37%
FVEP triplicates from one randomly selected eye in each of 17 horses were evaluated in a nested mixed-model with random effects. Some wavelets were
detected in all recordings, whereas others only in some replicates. Mean, intra-individual and inter-individual SD (SDintra-individual, SDinter-individual), as well as intra-
individual and inter-individual coefficients of variation (CVintra-individual and CVinter-individual respectively) are reported for each parameter
Table 2 Descriptive FVEP data for measurements from all 17
horses
Parameter Mean SD Range
P2 (ms) 54 4.0 46–59
N2 (ms) 136 9.0 117–152
P4 (ms) 213 25.3 170–271
N1P2 (μV) 4.1 2.7 1.6–10.2
P2N2 (μV) 7.1 3.3 3.8–13.8
N2P4 (μV) 7.7 3.1 3.7–13.9
Mean ± SD and range for measurements for each parameter from one
randomly selected eye in 17 horses
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time may often be sufficiently informative, as very few
patients are likely to have amplitudes that fall outside of
the normal range and only severe abnormalities will
cause sufficiently abnormal amplitudes.
The waveforms obtained from left and right eyes dur-
ing the same recording session were similar. The vari-
ability in peak times between eyes in the same horse was
low, only 7% or less. The variation has also been de-
scribed to be quite similar between eyes within the same
subject in humans [1]. This low inter-ocular variation
enhances evaluation of clinical patients with suspected
unilateral dysfunction, when one eye can serve as a con-
trol eye. The coefficients of repeatability reported in our
study represent the range within which the absolute dif-
ference between two measurements on the same subject
should fall with a 95% probability. Larger differences,
outside the range set by the CR values (P2; 5 ms, N2; 18
ms, P4; 18 ms), are likely to indicate abnormal function.
Again, amplitudes were shown to be more variable be-
tween eyes. However, the P2N2 and N2P4 amplitudes
may provide important information, with CR values at
1.7 μV and 2.3 μV, respectively.
The waveforms obtained at separate recording sessions
appeared quite similar. The coefficients of variation for
peak times between sessions were low (3–6%) but higher
for amplitudes (24–30%), which is similar to the variabil-
ity shown between eyes within the same session. Bland-
Altman plots with 95% limits of agreement were used to
graphically examine the agreement between two mea-
surements from separate recording sessions. The plots
show that the mean difference between sessions is low
for the P2 peak time, but higher for the N2 and P4 peak
times. The mean differences were similar across all amp-
litude parameters. The coefficients of repeatability were
computed to quantify the absolute repeatability in the
same unit as the parameter with a probability of 95%.
Based on our results, differences in peak times between
recording sessions falling outside the reported CR values
Fig. 2 FVEP tracings from left and right eyes. Two tracings each
from left and right eyes (OS and OD) recorded at the same session
in four horses (horses 2–3, 12 and 14)
Table 3 Comparison of FVEP measurements from left and right
eyes
OD OS
Parameter Mean SD Mean SD p-value CV CR
P2 (ms) 52 5.7 52 6.0 0.56 3% 5
N2 (ms) 138 8.1 134 10.8 0.33 5% 18
P4 (ms) 200 12.4 197 17.7 0.40 3% 18
N1P2 (μV) 2.5 0.9 2.5 1.3 0.99 28% 2.0
P2N2 (μV) 5.2 1.5 5.5 1.4 0.42 11% 1.7
N2P4 (μV) 5.9 2.6 6.3 2.7 0.43 14% 2.3
Results from recordings from left and right eyes (OS and OD, respectively)
obtained from eight horses during the same recording session. Mean ± SD for
left and right eyes. A paired t-test was used to evaluate results from left and
right eyes, p-values< 0.05 were considered statistically significant. Coefficients
of variation (CV) and coefficients of repeatability (CR) are reported
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(P2; 5 ms, N2; 16ms, P4; 39ms), are likely to indicate ei-
ther an improvement or deterioration of a condition. For
the amplitudes, the CR values are higher, again supporting
the conclusion that differences in amplitudes between ses-
sions only rarely will provide reliable information regard-
ing the progression of a disease or effect of a treatment.
The ICC is a widely used reliability index in test-retest
analyses [18]. In our study on the equine FVEP, we found
that the ICC values ranged from fair (N2 peak time) to ex-
cellent (P2 peak time and P2N2 amplitude) according to
the grading system proposed by Cicchetti [19].
Some of the variability in our data is due to difficulties
in establishing the peak or trough of a specific wavelet
precisely. Large amplitude, pointed wavelets are gener-
ally easier to pinpoint compared to low-amplitude, or
more rounded or elongated wavelets. N1 was usually a
low-amplitude wavelet, where the trough sometimes was
difficult to localize precisely. P2, on the other hand, was
most often a distinct peak that was easy to discriminate.
Thus, it is not surprising that the P2 peak time showed
least variability and highest repeatability and reliability.
Although the N2-complex always was easy to identify,
this complex was sometimes wide with a flat bottom
(not a distinct trough), and sometimes also included
N2a and P3. Therefore, the exact position of N2 was oc-
casionally difficult to determine. P4 was also most often
easily discriminated, but in some horses this wavelet was
wide without a distinct peak (for example horse 3 in Fig.
2), which made precise marking difficult. In spite of dif-
ferences in the precise localization of some wavelets, co-
efficients of variation were low for P2, N2 and P4 peak
times. The coefficients of repeatability, which represent
the absolute difference between measurements (in the
same unit as the parameter), show higher values for both
N2 and P4 peak times compared to P2 peak time, which
altogether is not surprising.
The difficulties in the precise localization of wavelets
certainly affected the amplitude measurements for the
same reasons mentioned above, although probably not
as much as peak times according to our subjective as-
sessment. The large variability shown for amplitudes is
more likely due to other factors, such as variation in the
level of sedation, muscle and movement artifacts, the
temperament of the horse and its responses to external
disturbances in the clinical environment. The variation
between sessions may also be attributed to minor differ-
ences in electrode positions between sessions.
Andersson et al. [9] evaluated the test-retest properties
of the human FVEP in 15 awake, normal subjects at
three separate recording sessions. They found that pre-
cise marking of wavelets was sometimes difficult, due to
split peaks and highly variable waveforms within and be-
tween individuals. Wide inter-individual ranges for both
N2 and P2 peak times and amplitudes (the parameters
they evaluated) were described, and a high intra-
individual variability over time was reported. Specifically,
they concluded that due to the large variability, the
FVEP is unreliable as a tool for detecting increased
intracranial pressure which had previously been sug-
gested by other authors. Therefore, they advised caution
when interpreting changes in FVEPs in clinical work. It
is not possible to make direct comparisons between hu-
man and equine FVEPs, because of differences in the
overall waveform between species, different electrode
positions due to anatomical dissimilarities, and the fact
that our horses were sedated and their human subjects
fully awake. All these differences may certainly have an
Fig. 3 FVEP tracings from separate sessions. Two representative
tracings from each of two separate recording sessions in three
horses (horses 2, 3 and 6)
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impact on the variability. However, some comparisons
may still be relevant. We saw some individual variation
in waveforms between horses (Fig. 2 and Fig. 3), which
is similar to what was described by Andersson et al. [9]
in their human subjects. As in our study, Andersson
et al. [9] report that deciding on the exact position of a
peak or trough of a wavelet was sometimes difficult.
However, our impression is that the wavelets were
somewhat easier to discriminate in the equine FVEPs
compared to the human FVEPs. Also, split peaks were
not as prominent and frequent as described by Anders-
son et al. [9] in some human subjects. The range is
narrower for P2 and N2 peak times in the equine FVEP
(Table 2), compared to more than 50-ms-intervals con-
sidered to represent the normal ranges for N2 and P2 in
the human study.
A limitation of our study is the small sample size, which
is due to limited access to horses available for the study.
Reported values for reliability and repeatability should
therefore be interpreted with some caution. In addition,
further studies are needed, to evaluate equine FVEPs in
horses with diseases in visual pathways, causing visual im-
pairment. Although we have provided CR values between
eyes and sessions in equine FVEPs, their clinical signifi-
cance warrants further studies. Differences lower than the
reported CR values (between eyes and sessions) can still
be of importance, because mild dysfunction of the visual
pathways may still be present. Therefore, results from
FVEP testing should always be put into context with other
findings and results from additional tests obtained during
work-up of a patient, including for example ophthalmic
and neuro-ophthalmologic examinations, obstacle course
testing and diagnostic imaging.
Conclusions
In summary, this study provides important data on vari-
ability, repeatability and test-retest reliability of FVEPs in
normal, adult horses. Based on our data, we conclude
that P2, N2 and P4 peak times should be included in the
Fig. 4 Bland-Altman plots to compare measurements between sessions. Bland-Altman plots with 95% limits of agreement for the mean
difference (six horses). The mean measurement from the first and second recording session (x-axis) was plotted against the difference between
the two measurements (y-axis). The mean difference was the estimated bias (dotted red lines). Limits of agreement are marked as blue
dotted lines
Table 4 Comparison of FVEP measurements from two sessions
Session 1 Session 2
Parameter Mean SD Mean SD p-value CV CR ICC
P2 (ms) 55 5.2 56 5.5 0.65 3% 5 87%
N2 (ms) 142 8.3 139 7.9 0.55 4% 16 43%
P4 (ms) 234 20.4 227 28.8 0.66 6% 39 63%
N1P2 (μV) 6.8 2.9 5.4 3.8 0.52 30% 5.1 67%
P2N2 (μV) 9.7 4.4 7.8 4.8 0.49 24% 5.7 78%
N2P4 (μV) 8.6 4.2 7.7 4.0 0.69 27% 6.1 66%
Results from unilateral FVEPs from six horses at two separate recording
sessions months apart. Mean ± SD for first and second sessions. A paired t-test
was used to compare results from the two sessions, p-values< 0.05 were
considered statistically significant. Coefficients of variation (CV), coefficients of
repeatability (CR) and intraclass correlation coefficients (ICC) are reported
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evaluation of equine FVEPs. The large inherent variabil-
ity of FVEP amplitudes is likely to make them less suit-
able and useful in most clinical patients, but they may
occasionally provide support to a clinical diagnosis. Al-
though all laboratories performing electrophysiological
examinations are recommended to produce and use own
normative data when evaluating clinical patients, this
study provide information on the magnitude of the vari-
ability and repeatability that can be expected in the nor-
mal horse. To assess the full potential of FVEPs as a
diagnostic aid in equine clinical practice, further evalu-
ation of results from horses with visual impairment of
different etiologies is warranted.
Methods
Horses
Seventeen healthy adult Standardbreds (3–19 years old,
mean ± standard deviation (SD); 10 ± 5.7 years, 4 geld-
ings, 2 stallions and 11 mares), without any signs of ocu-
lar, visual or neurological disease at physical and
ophthalmic examination, including obstacle course test-
ing, were included in the study. Horses 1–10 and 1–17
were also included in two previous studies [16, 17]. The
study was approved by the Regional Ethical Committee
(Uppsala Djurförsöksetiska nämnd, Sweden, C254/10
and C39/12). The experiments were carried out follow-
ing national and institutional guidelines for care and use
of animals in research. All horses were owned by the
Swedish University of Agricultural Sciences and they
were alive and healthy after the experiments.
FVEPs
Light-adapted FVEPs were recorded according to the
protocol described by Ström & Ekesten [17]. All record-
ings were performed in a clinical examination room at
the Horse Clinic at the Swedish University of Agricul-
tural Sciences. Horses were sedated with an intravenous
bolus injection of detomidine, 0.01 mg/kg (Domosedan
vet., 10 mg/ml, Orion Pharma Animal Health, Sollen-
tuna, Sweden) followed by maintenance of sedation
throughout the recording sessions using a continuous
intravenous infusion of 2% detomidine in physiologic sa-
line solution (Natriumklorid, 9 mg/ml, Fresenius Kabi,
Uppsala, Sweden), to keep the horse resting its head
steadily on a padded headstand. Pupils were dilated
(Mydriacyl, 0.5%, Novartis, Stockholm, Sweden), akinesia
and analgesia of the eyelids and electrode positions were
performed to avoid muscle artifacts (Carbocain, 20 mg/
ml, AstraZeneca, Södertälje, Sweden), and topical cor-
neal anesthesia was applied (Tetrakain, 1%, Bausch &
Lomb Nordic AB, Stockholm, Sweden). The room was
kept dark during recordings to avoid stray light. The fel-
low eye was covered by a black, opaque plastic eye
shield, and cotton wads were used in the ears to reduce
auditory stimuli.
Cork-screw electrodes were used (Stainless Steel Dis-
posabel Corkscrew Electrode, Cephalon A/S, Nörre-
sundby, Denmark). The active electrode was placed at
Pz-45, the ground and reference electrode were placed on
the forehead in the midline according to Ström & Ekes-
ten [16]. Electrode impedance was kept below 5 kΩ. The
flash stimulus was elicited by a handheld dome-shaped
LED-photostimulator with a background light intensity
of 25 cd/m2, a flash intensity of 3 cd/m2/s and a flash
duration of 5 ms. The stimuli were presented at a fre-
quency of 1.09 Hz. The recording window was 500 ms.
Responses were amplified (amplifier set to × 104), aver-
aged (100–144 averages), band-pass filtered (1–100 Hz),
stored and analyzed using the An-Vision RETI-port
(An-Vision, Hennigsdorf, Germany) and a laptop com-
puter. Light-adapted ERGs were recorded simultan-
eously to assure that a normal response was generated
by the retina.
The same examiner (LS) performed all recordings.
Equine FVEPs were recorded from one randomly se-
lected eye in 17 horses (left eye; OS, right eye; OD), in
both eyes (OU) in eight horses and also at two separate
recording sessions (2–11 months apart, median 7.5
months) in six horses (Table 5). According to the human
standard protocol of the International Society for Clin-
ical Electrophysiology of Vision (ISCEV) [1], a minimum
of two reproducible recordings should be performed in
clinical VEP testing. Obtaining several reproducible rep-
licates is described to be even more important in
pediatric subjects, to assure that the response recorded
is a reliable signal and not an artifact due to poor co-
operation. Therefore, from the horses in our study
(which may be compared to slightly uncooperative
pediatric subjects), we chose to obtain three replicates
from each horse and eye stimulated.
Data analysis
One author (LS) performed all markings of tracings to
avoid investigator dependent variability. Wavelets were
identified and named in accordance with the previously
described FVEP waveform in horses (Fig. 1) [16]. Peak
times and amplitudes were evaluated according to estab-
lished guidelines [16, 20]. Blinded marking of each iden-
tified parameter in all three replicates was performed.
Data were assessed for normality by visual examination
of residual plots prior to analysis. Parameters were tested
for homogeneity of variance using Levene’s test. Statis-
tical analysis was performed using a statistical software
(JMP® Pro 14.0.0). The level of statistical significance
was defined at p < 0.05.
To assess the intra- and inter-variability of the three
replicates for each parameter (peak times and
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amplitudes), a nested mixed-model with random effects
was used. Only peak times and amplitudes containing
100% recordings were used for the remainder of the ana-
lyses. The average of the three replicates were calculated
and used as one measurement for each parameter, when
comparing results between eyes (eight horses) and be-
tween sessions (six horses). Parameters were compared
between left and right eyes, and between sessions for the
same eye using a paired t-test. The repeatability for mea-
sured parameters between eyes in the same horse during
the same recording session, as well as the repeatability
for the same parameters for the same eye on different
sessions were determined by the coefficient of variation
(CV) and coefficient of repeatability (CR), whereas ICC
was used to evaluate test-retest reliability between
sessions.
Coefficient of variation is a measure of the relative
variability, and was calculated using the SD within and
between subjects obtained from one way ANOVA
(within) or a nested mixed model (within and between)
[21]. Coefficient of repeatability shows the absolute dif-
ference in peak time and amplitudes between measure-
ments, and was computed according to the formula:
1:96
ffiffiffi
2
p
 SDwithin subject
based on results from an ANOVA table [18]. Intraclass
correlation coefficients (ICCs) were calculated to assess
and quantify test-retest reliability for measurements
between sessions. The ICC was calculated from an
ANOVA table according to the formula
ICC ¼ Sb2= Sb2 þ Sw2
 
where the Sw
2 is defined as the within-subjects variance
and Sb
2 as the between-subjects variance [18]. There is
no universally agreed level for ICC values, but the often
quoted guidelines by Cicchetti [19] were used for inter-
pretation of ICC reliability: poor: < 0.40, fair: 0.40–0.59,
good: 0.60–0.74, excellent: 0.75–1.00.
Bland-Altman plots including 95% upper and lower
limits of agreement were constructed based on measure-
ments from recordings at two separate sessions [22, 23].
The average measurement from the two recording ses-
sions for each subject was plotted against the difference
between measurements to assess repeatability between
sessions.
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